A small-molecule degron with a phenylpropionic acid scaffold

[Display omitted] Targeted protein degradation (TPD), employing proteolysis-targeting chimeras (PROTACs) composed of ligands for both a target protein and ubiquitin ligase (E3) to redirect the ubiquitin–proteasome system (UPS) to the target protein, has emerged as a promising strategy in drug discov...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2024-07, Vol.109, p.117789, Article 117789
Hauptverfasser: Tomoshige, Shusuke, Komatsu, Fumiko, Kikuchi, Tomoko, Sugiyama, Miku, Kawasaki, Yushi, Ohgane, Kenji, Furuyama, Yuuki, Sato, Shinichi, Ishikawa, Minoru, Kuramochi, Kouji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] Targeted protein degradation (TPD), employing proteolysis-targeting chimeras (PROTACs) composed of ligands for both a target protein and ubiquitin ligase (E3) to redirect the ubiquitin–proteasome system (UPS) to the target protein, has emerged as a promising strategy in drug discovery. However, despite the vast number of E3 ligases, the repertoire of E3 ligands utilized in PROTACs remains limited. Here, we report the discovery of a small-molecule degron with a phenylpropionic acid skeleton, derived from a known ligand of S-phase kinase-interacting protein 2 (Skp2), an E3 ligase. We used this degron to design PROTACs inducing proteasomal degradation of HaloTag-fused proteins, and identified key structural relationships. Surprisingly, our mechanistic studies excluded the involvement of Skp2, suggesting that this degron recruits other protein(s) within the UPS.
ISSN:0968-0896
1464-3391
1464-3391
DOI:10.1016/j.bmc.2024.117789